About Pathology Watch
Pathology Watch is a private company based in Murray, Utah. It has reported $28,930,983 raised in three offerings on Form D since May 2019. Its chief executive is Daniel Lambert.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Dec 29, 2021 | Mar 7, 2023 | $22,337,584of $25.0M target | 88 | $253K | EquityRule 506(c) | Form D ↗ |
| Apr 28, 2020 | May 13, 2020 | $4,255,038of $4.9M target | 23 | $185K | EquityRule 506(b) | Form D ↗ |
| Apr 23, 2019 | May 7, 2019 | $2,338,361of $3.1M target | 9 | $259K | EquityRule 506(b) | Form D ↗ |
| Total, three offerings | $28,930,983 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Pathology Watch's Form D filed Mar 7, 2023.
RS
Rick Stratford
Director
SM
Scott Mattivi
Executive officer
MT
Michael Torno
Executive officer and director
AW
Austin Walters
Director
AD
Arjun Desai
Director
DL
Daniel Lambert
Chief Executive Officer and director
Earlier filings also listed Yiannis Monovoukas (director, last listed May 2020) and Gregory Osmond (executive officer and director, last listed May 2020).